Regulation of α-synuclein by chaperones in mammalian cells
Open accessAbstract
Neurodegeneration in patients with Parkinson's disease is correlated with the occurrence of Lewy bodies-intracellular inclusions that contain aggregates of the intrinsically disordered protein α-synuclein 1. The aggregation propensity of α-synuclein in cells is modulated by specific factors that include post-translational modifications 2,3, Abelson-kinase-mediated phosphorylation 4,5 and interactions with intracellular machineries such as molecular chaperones, although the underlying mechanisms are unclear 6-8. Here we systematically characterize the interaction of molecular chaperones with α-synuclein in vitro as well as in cells at the atomic level. We find that six highly divergent molecular chaperones commonly recognize a canonical motif in α-synuclein, consisting of the N terminus and a segment around Tyr39, and hinder the aggregation of α-synuclein. NMR experiments 9 in cells show that the same transient interaction pattern is preserved inside living mammalian cells. Specific inhibition of the interactions between α-synuclein and the chaperone HSC70 and members of the HSP90 family, including HSP90β, results in transient membrane binding and triggers a remarkable re-localization of α-synuclein to the mitochondria and concomitant formation of aggregates. Phosphorylation of α-synuclein at Tyr39 directly impairs the interaction of α-synuclein with chaperones, thus providing a functional explanation for the role of Abelson kinase in Parkinson's disease. Our results establish a master regulatory mechanism of α-synuclein function and aggregation in mammalian cells, extending the functional repertoire of molecular chaperones and highlighting new perspectives for therapeutic interventions for Parkinson's disease.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hsp90 has a holdase function for p53-DBD and Tau by binding and protecting them from aggregation.
“This suggests that Hsp90 has a holdase function for these proteins by binding and protecting them from aggregation (69).”
From Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network (2021) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C., Oueslati, A., & Masliah, E. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3406 · Cited by 1,623 · see citing works
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540 · see citing works
Molecular Chaperone Functions in Protein Folding and Proteostasis
Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,468 · see citing works
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works
Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes
Shahmoradian, S. H., Lewis, A. J., Genoud, C., Hench, J., Moors, T. E., Navarro, P. P., Castaño‐Díez, D., Schweighauser, G., Graff-Meyer, A., Goldie, K. N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0423-2 · Cited by 974 · see citing works
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, Á., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 901 · see citing works
Structural disorder of monomeric α-synuclein persists in mammalian cells
Theillet, F., Binolfi, A., Bekei, B., Martorana, A., Rose, H. M., Stuiver, M., Verzini, S., Lorenz, D., van Rossum, M., Goldfarb, D., et al. (2016) · Nature · doi:10.1038/nature16531 · Cited by 877 · see citing works
Rüdiger, S., Germeroth, L., Schneider‐Mergener, J., & Bukau, B. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1501 · Cited by 815 · see citing works
Self-citationComposition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
Wilhelm, B. G., Mandad, S., Truckenbrodt, S., Kröhnert, K., Schäfer, C., Rammner, B., Koo, S. J., Claßen, G. A., Krauss, M., Haucke, V., et al. (2014) · Science · doi:10.1126/science.1252884 · Cited by 770 · see citing works
Structural basis of membrane disruption and cellular toxicity by α-synuclein oligomers
Fusco, G., Chen, S. W., Williamson, P. T. F., Cascella, R., Perni, M., Jarvis, J. A., Cecchi, C., Vendruscolo, M., Chiti, F., Cremades, N., et al. (2017) · Science · doi:10.1126/science.aan6160 · Cited by 665 · see citing works
Park, J.-S., Davis, R. L., & Sue, C. M. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0829-3 · Cited by 516 · see citing works
Regulation of the c-Abl and Bcr–Abl tyrosine kinases
Hantschel, O. D., & Superti‐Furga, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1280 · Cited by 491 · see citing works
Surface tension of amino acid solutions: A hydrophobicity scale of the amino acid residues
Bull, H. B., & Breese, K. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(74)90352-x · Cited by 461 · see citing works
Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins
Ferbitz, L., Maier, T., Patzelt, H., Bukau, B., Deuerling, E., & Ban, N. (2004) · Nature · doi:10.1038/nature02899 · Cited by 419 · see citing works
Human Hsp70 Disaggregase Reverses Parkinson’s-Linked α-Synuclein Amyloid Fibrils
Gao, X., Carroni, M., Nussbaum-Krammer, C. I., Mogk, A., Nillegoda, N. B., Szlachcic, A., Guilbride, D. L., Saibil, H. R., Mayer, M. P., & Bukau, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.012 · Cited by 404 · see citing works
Hsp90-Tau complex reveals molecular basis for specificity in chaperone action
Karagöz, G. E., Duarte, A. M. S., Akoury, E., Ippel, H., Biernat, J., Morán Luengo, T., Radli, M., Didenko, T., Nordhues, B. A., Veprintsev, D. B., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.037 · Cited by 318 · see citing works
Self-citationStructural basis for protein antiaggregation activity of the trigger factor chaperone.
Saio, T., Guan, X., Rossi, P., Economou, A., & Kalodimos, C. G. (2014) · Science · doi:10.1126/science.1250494 · Cited by 289 · see citing works
Dedmon, M. M., Christodoulou, J. C., Wilson, M. R., & Dobson, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413024200 · Cited by 235 · see citing works
Mahul‐Mellier, A., Fauvet, B., Gysbers, A. M., Dikiy, I., Oueslati, A., Georgeon, S., Lamontanara, A. J., Bisquertt, A., Eliezer, D., Masliah, E., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt674 · Cited by 220 · see citing works
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Maltsev, A. S., Ying, J., & Bax, A. (2012) · Biochemistry · doi:10.1021/bi300642h · Cited by 217 · see citing works
Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration
Brahmachari, S., Ge, P., Lee, S. H., Kim, D., Karuppagounder, S. S., Kumar, M., Mao, X., Shin, J. H., Lee, Y., Pletniková, O., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85456 · Cited by 199 · see citing works
Macromolecular Crowding in the Escherichia coli Periplasm Maintains α-Synuclein Disorder
McNulty, B. C., Young, G. B., & Pielak, G. J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.033 · Cited by 176 · see citing works
Finn, T., Nunez, A. C., Sunde, M., & Easterbrook‐Smith, S. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372961 · Cited by 162 · see citing works
Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson’s disease
Reeve, A. K., Grady, J. P., Cosgrave, E., Bennison, E., Chen, C., Hepplewhite, P. D., & Morris, C. M. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-018-0044-6 · Cited by 150 · see citing works
Korndörfer, I. P., Dommel, M. K., & Skerra, A. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb828 · Cited by 143 · see citing works
Burmann, B. M., Wang, C., & Hiller, S. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2677 · Cited by 132 · see citing works
Self-citationFalsone, S. F., Kungl, A., Rek, A., Cappai, R., & Zangger, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057240 · Cited by 129 · see citing works
Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/α‐synuclein complex by Hip
Roodveldt, C., Bertoncini, C. W., Andersson, A., van der Goot, A. T., Hsu, S. D., Fernández-Montesinos, R., de Jong, J., van Ham, T. J., Nollen, E. A. A., Pozo, D., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.298 · Cited by 125 · see citing works
Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein
Pemberton, S., Madiona, K., Pieri, L., Kabani, M., Bousset, L., & Melki, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261321 · Cited by 114 · see citing works
Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites
Binolfi, A., Limatola, A., Verzini, S., Kosten, J., Theillet, F., Rose, H. M., Bekei, B., Stuiver, M., van Rossum, M., & Selenko, P. (2016) · Nature Communications · doi:10.1038/ncomms10251 · Cited by 105 · see citing works
A molecular mechanism of chaperone-client recognition
He, L., Sharpe, T., Mazur, A., & Hiller, S. (2016) · Science Advances · doi:10.1126/sciadv.1601625 · Cited by 78 · see citing works
Self-citationWilson, M. R., Dedmon, M. M., Christodoulou, J. C., & Dobson, C. M. (2005) · Research Online (University of Wollongong) · Cited by 77 · see citing works
Kosten, J., Binolfi, A., Stuiver, M., Verzini, S., Theillet, F., Bekei, B., van Rossum, M., & Selenko, P. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5002254 · Cited by 66 · see citing works
Molecular Chaperones and Co-Chaperones in Parkinson Disease
Dimant, H., Ebrahimi‐Fakhari, D., & McLean, P. J. (2012) · The Neuroscientist · doi:10.1177/1073858412441372 · Cited by 55 · see citing works
Novel subcellular localization for α-synuclein: possible functional consequences
Guardia‐Laguarta, C., Área-Gómez, E., Schon, E. A., & Przedborski, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00017 · Cited by 51 · see citing works
Mahul‐Mellier, A., Altay, M. F., Burtscher, J., Maharjan, N., Ait‐Bouziad, N., Chiki, A., Vingill, S., Wade‐Martins, R., Holton, J. L., Strand, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/500058 · Cited by 45 · see citing works
Two‐Dimensional Crowding Uncovers a Hidden Conformation of α‐Synuclein
Banerjee, P. R., Moosa, M. M., & Deniz, A. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201606963 · Cited by 31 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mitochondrial dysfunction: mechanisms and advances in therapy
Yao, Z., Li, H., Liao, P., Chen, L., Pan, Y., Zheng, Y., Zhang, C., Liu, D., Zheng, M., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01839-8 · Cited by 1,276 · see citing works
Mechanisms and pathology of protein misfolding and aggregation
Louros, N. N., Schymkowitz, J. W. H., & Rousseau, F. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00647-2 · Cited by 259 · see citing works
Molecular dissection of amyloid disaggregation by human HSP70
Wentink, A. S., Nillegoda, N. B., Feufel, J., Ubartaitė, G., Schneider, C. P., Rios, P. D. L., Hennig, J., Barducci, A., & Bukau, B. (2020) · Nature · doi:10.1038/s41586-020-2904-6 · Cited by 231 · see citing works
Vidović, M., & Rikalović, M. (2022) · Cells · doi:10.3390/cells11111732 · Cited by 210 · see citing works
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Oliveira, L. M. A., Gasser, T., Edwards, R. H., Zweckstetter, M., Melki, R., Stefanis, L., Lashuel, H. A., Sulzer, D. L., Vekrellis, K., Halliday, G. M., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00203-9 · Cited by 169 · see citing works
Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
Stephens, A. D., Zacharopoulou, M., Moons, R., Fusco, G., Seetaloo, N., Chiki, A., Woodhams, P. J., Mela, I., Lashuel, H. A., Phillips, J. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16564-3 · Cited by 157 · see citing works
The cell biology of Parkinson’s disease
Panicker, N., Ge, P., Dawson, V. L., & Dawson, T. M. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202012095 · Cited by 164 · see citing works
In-Cell Structural Biology by NMR: The Benefits of the Atomic Scale
Theillet, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00937 · Cited by 126 · see citing works
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Tofaris, G. K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04240-2 · Cited by 121 · see citing works
Folding or holding?—Hsp70 and Hsp90 chaperoning of misfolded proteins in neurodegenerative disease
Rutledge, B. S., Choy, W., & Duennwald, M. L. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101905 · Cited by 110 · see citing works
Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease
Yan, Y., Zheng, R., Liu, Y., Ruan, Y., Lin, Z., Xue, N., Chen, Y., Zhang, B., & Pu, J. (2023) · Aging Cell · doi:10.1111/acel.13834 · Cited by 110 · see citing works
Ulamec, S. M., Brockwell, D. J., & Radford, S. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.611285 · Cited by 104 · see citing works
α-Synuclein pathology as a target in neurodegenerative diseases
Park, H.-J., Kam, T., Dawson, V. L., & Dawson, T. M. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01043-w · Cited by 113 · see citing works
NMR illuminates intrinsic disorder
Dyson, H. J., & Wright, P. E. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.03.015 · Cited by 100 · see citing works
Key genes and convergent pathogenic mechanisms in Parkinson disease
Coukos, R., & Krainc, D. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00812-2 · Cited by 102 · see citing works
Calabrese, G., Molzahn, C. M., & Mayor, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102062 · Cited by 90 · see citing works
Molecular chaperones and Parkinson's disease
Hu, S., Tan, J., Qin, L., Lv, L., Yan, W., Zhang, H., Tang, B., & Wang, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105527 · Cited by 90 · see citing works
Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease
Haque, M. E., Akther, M., Azam, S., Kim, I., Lin, Y., Lee, Y., & Choi, D. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15684 · Cited by 91 · see citing works
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
Ni, R., Chen, Z., Deán‐Ben, X. L., Voigt, F. F., Kirschenbaum, D. S., Shi, G., Villois, A., Zhou, Q., Crimi, A., Arosio, P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00906-1 · Cited by 83 · see citing works
Ohgita, T., Namba, N., Kono, H., Shimanouchi, T., & Saito, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-10789-6 · Cited by 85 · see citing works
Theillet, F., & Luchinat, E. (2022) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2022.04.002 · Cited by 82 · see citing works
Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy
Ayers, J. I., Lee, J., Monteiro, O., Woerman, A. L., Lazar, A. A., Condello, C., Paras, N. A., & Prusiner, S. B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113489119 · Cited by 78 · see citing works
Bhattacharya, K., & Picard, D. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03962-z · Cited by 73 · see citing works
Yang, X., Wang, B., Hoop, C. L., Williams, J. K., & Baum, J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017452118 · Cited by 71 · see citing works
Kurzawa‐Akanbi, M., Tammireddy, S. R., Fabrik, I., Gliaudelytė, L., Doherty, M. K., Heap, R. E., Matečko‐Burmann, I., Burmann, B. M., Trost, M., Lucocq, J. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02367-3 · Cited by 70 · see citing works
Self-citationAdvanced Techniques for Detecting Protein Misfolding and Aggregation in Cellular Environments
Bai, Y., Zhang, S., Dong, H. Y., Liu, Y., Liu, C., & Zhang, X. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00494 · Cited by 71 · see citing works
In-Cell Sensitivity-Enhanced NMR of Intact Viable Mammalian Cells
Ghosh, R., Xiao, Y., Kragelj, J., & Frederick, K. K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c06680 · Cited by 66 · see citing works
Client binding shifts the populations of dynamic Hsp90 conformations through an allosteric network
Lopez, A., Dahiya, V., Delhommel, F., Freiburger, L., Stehle, R., Asami, S., Rutz, D., Blair, L., Buchner, J., & Sattler, M. (2021) · Science Advances · doi:10.1126/sciadv.abl7295 · Cited by 59 · see citing works
Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism
Tao, J., Berthet, A., Citron, Y. R., Tsiolaki, P. L., Stanley, R. F., Gestwicki, J. E., Agard, D. A., & McConlogue, L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100613 · Cited by 58 · see citing works
Biebl, M. M., Lopez, A., Rehn, A., Freiburger, L., Lawatscheck, J., Blank, B., Sattler, M., & Buchner, J. (2021) · Nature Communications · doi:10.1038/s41467-021-21063-0 · Cited by 58 · see citing works
Zhang, C., Pei, Y., Zhang, Z., Xu, L., Liu, X., Jiang, L., Pielak, G. J., Zhou, X., Liu, M., & Li, C. (2022) · Communications Biology · doi:10.1038/s42003-022-03768-0 · Cited by 56 · see citing works
Single residue modulators of amyloid formation in the N-terminal P1-region of α-synuclein
Ulamec, S. M., Maya‐Martinez, R., Byrd, E. J., Dewison, K. M., Xu, Y., Willis, L. F., Sobott, F., Heath, G. R., van Oosten‐Hawle, P., Buchman, V. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32687-1 · Cited by 55 · see citing works
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Gadhe, L. G., Sakunthala, A., Mukherjee, S., Gahlot, N., Bera, R., Sawner, A. S., Kadu, P., & Maji, S. K. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106736 · Cited by 56 · see citing works
Hsp multichaperone complex buffers pathologically modified Tau
Moll, A., Ramirez, L. M., Ninov, M., Schwarz, J., Urlaub, H., & Zweckstetter, M. (2022) · Nature Communications · doi:10.1038/s41467-022-31396-z · Cited by 56 · see citing works
Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
Burtscher, J., Syed, M. M. K., Lashuel, H. A., & Millet, G. P. (2021) · Movement Disorders · doi:10.1002/mds.28544 · Cited by 53 · see citing works
Fonseca‐Ornelas, L., Viennet, T., Rovere, M., Jiang, H., Liu, L., Nuber, S., Ericsson, M., Arthanari, H., & Selkoe, D. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109333 · Cited by 50 · see citing works
Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly
Ahmed, J., Fitch, T. C., Donnelly, C. M., Joseph, J. A., Ball, T. D., Bassil, M. M., Son, A., Zhang, C., Ledreux, A., Horowitz, S. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29724-4 · Cited by 46 · see citing works
Ellagic Acid Inhibits α-Synuclein Aggregation at Multiple Stages and Reduces Its Cytotoxicity
Kumar, S., Kumar, R., Kumari, M., Kumari, R., Saha, S., Bhavesh, N. S., & Maiti, T. K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00001 · Cited by 46 · see citing works
Ding, Y., Korchak, S. E., Mamone, S., Jagtap, A. P., Stevanato, G., Sternkopf, S., Moll, D., Schroeder, H., Becker, S., Fischer, A., et al. (2022) · Chemistry - Methods · doi:10.1002/cmtd.202200023 · Cited by 46 · see citing works
The interplay between α-Synuclein and NLRP3 inflammasome in Parkinson's disease
Huang, Q., Yang, P., Liu, Y., Ding, J., Lu, M., & Hu, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115735 · Cited by 43 · see citing works
Structural basis of client specificity in mitochondrial membrane-protein chaperones
Sučec, I., Wang, Y., Dakhlaoui, O., Weinhäupl, K., Jores, T., Costa, D., Hessel, A., Brennich, M., Rapaport, D., Lindorff‐Larsen, K., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd0263 · Cited by 43 · see citing works
Vagenknecht, P., Luzgin, A., Ono, M., Ji, B., Higuchi, M., Noaín, D., Maschio, C., Sobek, J., Chen, Z., Konietzko, U., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05708-w · Cited by 42 · see citing works
Self-citationKnecht, L. H., Folke, J., Dodel, R. C., Ross, J. A., & Albus, A. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01288-7 · Cited by 44 · see citing works
A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion
Santos, J., Cuéllar, J., Pallarès, I., Byrd, E. J., Lends, A., Moro, F., Abdul-Shukkoor, M. B., Pujols, J., Velasco‐Carneros, L., Sobott, F., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c02262 · Cited by 42 · see citing works
Pan, B., Rhoades, E. R., & Petersson, E. J. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b01038 · Cited by 42 · see citing works
Hervás, R., & Oroz, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239186 · Cited by 43 · see citing works
Melnik, B. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031059 · Cited by 42 · see citing works
Khare, S. D., Chinchilla, P., & Baum, J. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102579 · Cited by 40 · see citing works
Metamorphism in TDP-43 prion-like domain determines chaperone recognition
Carrasco, J., Antón, R., Valbuena, A., Pantoja‐Uceda, D., Mukhi, M., Hervás, R., Laurents, D. V., Gasset, M., & Oroz, J. (2023) · Nature Communications · doi:10.1038/s41467-023-36023-z · Cited by 39 · see citing works
Chai, Z., Wu, Q., Cheng, K., Liu, X., Zhang, Z., Jiang, L. F., Zhou, X., Liu, M., & Li, C. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300318 · Cited by 38 · see citing works
Nanomaterials as novel agents for amelioration of Parkinson’s disease
Wu, J., Cui, X., Ke, P. C., Mortimer, M., Wang, X., Bao, L., & Chen, C. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101328 · Cited by 37 · see citing works
Taking Charge: Metal Ions Accelerate Amyloid Aggregation in Sequence Variants of α-Synuclein
Byrd, E. J., Wilkinson, M., Radford, S. E., & Sobott, F. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00379 · Cited by 34 · see citing works
Liu, M., Xiao, R., Li, X., Zhao, Y., & Huang, J.-H. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70078 · Cited by 36 · see citing works
Catalysis of proline isomerization and molecular chaperone activity in a tug-of-war
Favretto, F., Flores‐Solis, D., Baker, J. D., Strohäker, T., Andreas, L. B., Blair, L. J., Becker, S., & Zweckstetter, M. (2020) · Nature Communications · doi:10.1038/s41467-020-19844-0 · Cited by 33 · see citing works
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity
Olsen, A. L., & Feany, M. Β. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105482 · Cited by 35 · see citing works
Truncation or proteolysis of α-synuclein in Parkinsonism
Suthar, S. K., & Lee, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101978 · Cited by 32 · see citing works
Graves, N. J., Gambin, Y., & Sierecki, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512134 · Cited by 34 · see citing works
Yoo, H., Lee, J., Kim, B., Moon, H., Jeong, H., Lee, K., Song, W., Hur, J. K., & Oh, Y. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.7.073 · Cited by 34 · see citing works
Common sequence motifs of nascent chains engage the ribosome surface and trigger factor
Deckert, A., Cassaignau, A. M. E., Wang, X., Włodarski, T., Chan, S. H. S., Waudby, C. A., Kirkpatrick, J., Vendruscolo, M., Cabrita, L. D., & Christodoulou, J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103015118 · Cited by 32 · see citing works
Lipid Homeostasis and Its Links With Protein Misfolding Diseases
Vendruscolo, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.829291 · Cited by 33 · see citing works
When Small becomes Too Big: Expanding the Use of In‐Cell Solid‐State NMR Spectroscopy
Narasimhan, S., Folkers, G. E., & Baldus, M. (2020) · ChemPlusChem · doi:10.1002/cplu.202000167 · Cited by 32 · see citing works
Brain-gut-microbiota axis in Parkinson’s disease: A historical review and future perspective
Dong, S., Sun, M., He, C. H., & Cheng, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.02.015 · Cited by 32 · see citing works
Miller, S., Campbell, C. E., Jimenez-Corea, H. A., Wu, G., & Logan, R. A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824191 · Cited by 32 · see citing works
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 34 · see citing works
27‐Hydroxycholesterol Drives the Spread of α‐Synuclein Pathology in Parkinson's Disease
Dai, L., Wang, J., Zhang, X., Yan, M., Zhou, L., Zhang, G., Meng, L., Chen, L., Cao, X., Zhang, Z., et al. (2023) · Movement Disorders · doi:10.1002/mds.29577 · Cited by 31 · see citing works
Ramezani, M., Wagenknecht-Wiesner, A., Wang, T., Holowka, D. A., Eliezer, D., & Baird, B. A. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00578-x · Cited by 30 · see citing works
Tiwari, S., Singh, A., Gupta, P., & Singh, S. (2022) · Cells · doi:10.3390/cells11233770 · Cited by 29 · see citing works
Lackie, R. E., de Miranda, A. S., Lim, M. P., Novikov, V., Madrer, N., Karunatilleke, N. C., Rutledge, B. S., Tullo, S., Brickenden, A. M., Maitland, M. E. R., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02491-8 · Cited by 29 · see citing works
The known unknowns of the Hsp90 chaperone
Silbermann, L., Vermeer, B., Schmid, S., & Tych, K. M. (2024) · eLife · doi:10.7554/elife.102666 · Cited by 30 · see citing works
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins
Sirtori, R., Riva, C., Ferrarese, C., & Sala, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135272 · Cited by 28 · see citing works
Zhang, R., Chen, X., Cheng, Y., Chen, Z., Li, X., & Deng, Y. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215616 · Cited by 27 · see citing works
Progress, Challenges and Opportunities of NMR and XL-MS for Cellular Structural Biology
Zhang, Z., Zhao, Q., Gong, Z., Du, R., Liu, M., Zhang, Y., Zhang, L., & Li, C. (2024) · JACS Au · doi:10.1021/jacsau.3c00712 · Cited by 27 · see citing works
Wang, Z., Wen, H., Zheng, C., Wang, X., Yin, S., Song, N., & Liang, M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c17416 · Cited by 27 · see citing works
Ni, R., Chen, Z., Gerez, J., Shi, G., Zhou, Q., Riek, R., Nilsson, K. P. R., Razansky, D., & Klohs, J. (2020) · Biomedical Optics Express · doi:10.1364/boe.395803 · Cited by 22 · see citing works
Self-citationParkinson’s disease and translational research
Dinter, E., Saridaki, T., Diederichs, L., Reichmann, H., & Falkenburger, B. H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00223-0 · Cited by 28 · see citing works
The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson’s disease
Dai, L., Wang, J., Meng, L., Zhang, X., Xiao, T., Deng, M., Chen, G., Xiong, J., Ke, W., Hong, Z., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002974 · Cited by 26 · see citing works
Eymsh, B., Drobny, A., Heyn, T. R., Xiang, W., Lucius, R., Schwarz, K., Keppler, J. K., Zunke, F., & Arnold, P. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00629 · Cited by 26 · see citing works
Phase separation-mediated biomolecular condensates and their relationship to tumor
Wang, X., Liu, J., Mao, C., & Mao, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01518-9 · Cited by 25 · see citing works
The dynamic triage interplay of Hsp90 with its chaperone cycle and client binding
Qu, X., Wang, S., Zhao, S., Wan, C., Xu, W., & Huang, C. (2024) · Nature Communications · doi:10.1038/s41467-024-55026-y · Cited by 24 · see citing works
Sheng, J., Olrichs, N. K., Gadella, B. M., Kaloyanova, D. V., & Helms, J. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186530 · Cited by 25 · see citing works
Redefining Molecular Chaperones as Chaotropes
Macošek, J., Mas, G., & Hiller, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.683132 · Cited by 24 · see citing works
Self-citationEffects of the Toxic Metals Arsenite and Cadmium on α-Synuclein Aggregation In Vitro and in Cells
Lorentzon, E., Horváth, I., Kumar, R., Rodrigues, J. I., Tamás, M. J., & Wittung-Stafshede, P. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111455 · Cited by 24 · see citing works
Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly
Wu, X., Ma, F., Pan, B., Zhang, Y., Zhu, L., Dèng, F., Xu, L., Zhao, Y., Yin, X., Niu, H., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200192 · Cited by 24 · see citing works
Gerez, J., Prymaczok, N. C., Kadavath, H., Ghosh, D., Bütikofer, M., Fleischmann, Y., Güntert, P., & Riek, R. (2022) · Communications Biology · doi:10.1038/s42003-022-04251-6 · Cited by 23 · see citing works
Self-citationBeriashvili, D., Yao, R., D’Amico, F., Krafčíková, M., Gurinov, A., Safeer, A., Cai, X., Mulder, M. P. C., Liu, Y., Folkers, G. E., et al. (2023) · Chemical Science · doi:10.1039/d3sc02117c · Cited by 24 · see citing works
Structural basis of DegP protease temperature-dependent activation
Šulskis, D., Thoma, J., & Burmann, B. M. (2021) · Science Advances · doi:10.1126/sciadv.abj1816 · Cited by 23 · see citing works
Self-citationMultivalent protein–protein interactions are pivotal regulators of eukaryotic Hsp70 complexes
Johnson, O. T., & Gestwicki, J. E. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01281-1 · Cited by 23 · see citing works
Fatal attraction – The role of hypoxia when alpha-synuclein gets intimate with mitochondria
Burtscher, J., Syed, M. M. K., Keller, M. A., Lashuel, H. A., & Millet, G. P. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.017 · Cited by 23 · see citing works
Biomolecular Perturbations in In-Cell Dynamic Nuclear Polarization Experiments
Overall, S. A., & Barnes, A. B. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.743829 · Cited by 22 · see citing works
Xiao, Y., Ghosh, R., & Frederick, K. K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.789478 · Cited by 21 · see citing works
Chopra, G., Shabir, S., Yousuf, S., Kauts, S., Bhat, S. A., Mir, A. H., & Singh, M. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03042-8 · Cited by 22 · see citing works
Schorova, L., Bedard, N., Khayachi, A., Ho, H.-H., Bolivar-Pedroso, J., Huynh, J., Piccirelli, M., Wang, Y., Plourde, M., Luo, W., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00601-1 · Cited by 19 · see citing works
Abdelaziz, A. M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114692 · Cited by 20 · see citing works
A RaPID Macrocyclic Peptide That Inhibits the Formation of α‐Synuclein Amyloid Fibrils
Ikenoue, T., Oono, M., So, M., Yamakado, H., Arata, T., Takahashi, R., Kawata, Y., & Suga, H. (2023) · ChemBioChem · doi:10.1002/cbic.202300320 · Cited by 21 · see citing works
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
Ohgita, T., Kono, H., Morita, I., Oyama, H., Shimanouchi, T., Kobayashi, N., & Saito, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-38070-4 · Cited by 20 · see citing works
Large Chaperone Complexes Through the Lens of Nuclear Magnetic Resonance Spectroscopy
Karamanos, T. K., & Clore, G. M. (2022) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-090921-120150 · Cited by 20 · see citing works
The inhibitory action of the chaperone BRICHOS against the α-Synuclein secondary nucleation pathway
Ghosh, D., Torres, F., Schneider, M. M., Ashkinadze, D., Kadavath, H., Fleischmann, Y., Mergenthal, S., Güntert, P., Krainer, G., Andrzejewska, E. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54212-2 · Cited by 19 · see citing works
Self-citationPons, M., Loftus, N., Vialaret, J., Moreau, S., Lehmann, S., & Hirtz, C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.818606 · Cited by 16 · see citing works
UBA52 Attunes VDAC1-Mediated Mitochondrial Dysfunction and Dopaminergic Neuronal Death
Tiwari, S., Singh, A., Gupta, P., Amrutha, K., & Singh, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00579 · Cited by 19 · see citing works
Cellular Applications of DNP Solid‐State NMR – State of the Art and a Look to the Future
Beriashvili, D., Zhou, J., Liu, Y., Folkers, G. E., & Baldus, M. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400323 · Cited by 19 · see citing works
- Authors
- Burmann, B. M., Gerez, J. A., Matečko-Burmann, I., Campioni, S., Kumari, P., Ghosh, D., Mazur, A., Aspholm, E. E., Šulskis, D., Wawrzyniuk, M., Bock, T., Schmidt, A., Rüdiger, S. G. D., Riek, R., & Hiller, S.
- Affiliations
- University of Basel (CH)
- ETH Zurich (CH)
- Wallenberg Centre for Molecular and Translational Medicine (SE)
- Utrecht University (NL)
- Corresponding author
- Burmann, Björn M.
- Riek, Roland
- Hiller, Sebastian
- ORCID
- Venue
- Nature
- Published
- 2019-12-04
- Volume
- 577
- Issue
- 7788
- Pages
- 127-132
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6930850
- OpenAlex
- W2992154881
- Cited by
- 255
- References
- 38
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 38 · 2023: 56 · 2022: 53 · 2021: 36 · 2020: 27 · 2019: 1
- FWCI
- 20.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- edoc (University of Basel) (acceptedVersion)
- DORA Empa (Swiss Federal Laboratories for Materials Science and Technology (Empa)) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Gothenburg University Publications Electronic Archive (Gothenburg University) (submittedVersion)
- edoc (University of Basel)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (166426, 148238, 164425, 128419)
- Vetenskapsrådet
- Göteborgs Universitet
- Wallenberg Centre for Molecular and Translational Medicine
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, molecular chaperones, Parkinson's disease, protein aggregation, Hsc70, HSP90, HSP90β, Abelson kinase, mitochondrial localization, Lewy bodies, intrinsically disordered proteins, neurodegeneration
- MeSH terms
- Cell Survival, Humans, Magnetic Resonance Spectroscopy, Protein Processing, Post-Translational, Molecular Chaperones, alpha-Synuclein, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
